OSSIO
Robert Lundquist has extensive work experience in the medical sales industry. Robert started their career at Stryker in 2013, where they held the position of Regional Sales Manager until 2018. Following this, they worked at Heraeus Medical as a Regional Director from 2018 to 2019. Currently, Robert serves as the Area Sales Director at OSSIO, Ltd.
Robert Lundquist attended The University of Kansas from 1993 to 1997, where they obtained a Bachelor of Arts degree with a double major in Biology and Communications.
This person is not in any offices
OSSIO
OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.